A Study of LM-24C5 For Advanced Solid Tumors

NCT06187402 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

RECRUITING

Status

49

Enrollment

INDUSTRY

Sponsor class

Conditions

Advanced Solid Tumor

Interventions

DRUG: LM-24C5

Sponsor

LaNova Medicines Limited